The Impact of Clinical Pharmacist in the Identification and Management of Treatment Related Problems in the Surgery Ward

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-09-29

Study Completion Date

2020-02-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients in the surgery ward are at risk of morbidity and mortality from various types of treatment-related problems (TRPs). The primary aim of this study is to assess the impact of the clinical pharmacist in the identification and management of TRPs in the surgery ward.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Pharmacists Role in the Management of Hypertension in Jordan

NCT01079494

Hypertension

COMPLETED NA

Impact of Pharmacists Directed Medication Reconciliation on Reducing Medication Discrepancies in a Surgery Ward

NCT03928106

Safety Issues

COMPLETED NA

The Role of a Clinical Pharmacist in the Management of Type 2 Diabetic Patients in a Primary Medical Center in Jordan

NCT06029842

Pharmacist-Patient Relations

COMPLETED NA

Impact of Mulstidisciplinary Medication Assessment Review in Surgery Departments

NCT03827031

Chronic Disease

RECRUITING NA

Clinical Pharmacist-led Inpatient Anticoagulation Stewardship Program

NCT03812848

Deep Vein Thrombosis Atrial Fibrillation Mitral Valve Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients were randomly assigned to intervention (n=50) and usual care (n=50) arms. The clinical pharmacist assessed the types, frequencies, and clinical significance of TRPs for all recruited patients at baseline. Patients and treating surgeons in the intervention arm received recommendations concerning the identified TRPs, while the usual care arm did not. The number of TRPs was reevaluated at follow-up.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgical Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

All patients were followed up prospectively for their length of hospital stay, and recommendations concerning each identified TRP were provided to the surgeons responsible for patients in the intervention group. Likewise, patient counseling and encouraging adherence to therapy were provided solely to patients in the intervention group. Patients in the control group received usual care by the surgical team without a coordinated contribution from the clinical pharmacist.

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Clinical pharmacist intervention + usual care arm

Patients in the clinical pharmacist intervention + usual care arm received the clinical pharmacist intervention as well as usual care provided by the surgical team

Group Type EXPERIMENTAL

clinical pharmacist intervention

Intervention Type OTHER

clinical pharmacist intervention

Usual care arm (Control arm)

Patients in the control arm received usual care by the surgical team without a coordinated contribution from the clinical pharmacist

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

clinical pharmacist intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Admission for elective, urgent, or emergency surgery
* age 18 years or older
* Expected length of stay of 3 days or more in the general surgical ward or the SICU